
Sino Biological/MYD88 cDNA ORF Clone, Rat, N-HA tag/1/RG80819-NY
商品编号:
RG80819-NY
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
MYD88 cDNA ORF Clone, Rat, N-HA tag: General Information
Gene
Species
Rat
NCBI Ref Seq
NM_198130.1
RefSeq ORF Size
891 bp
Description
Full length Clone DNA of Rat myeloid differentiation primary response 88 with N terminal HA tag.
Plasmid
Promoter
Enhanced CMV promoter
Vector
pCMV3-N-HA
Tag Sequence
HA Tag Sequence: TATCCTTACGACGTGCCTGACTACGCC
Sequencing Primers
T7( 5" TAATACGACTCACTATAGGG 3" )BGH( 5" TAGAAGGCACAGTCGAGG 3" )
Quality Control
The plasmid is confirmed by full-length sequencing.
Screening
Antibiotic in E.coli
Kanamycin
Antibiotic in Mammalian cell
Hygromycin
Application
Stable or Transient mammalian expression
Storage & Shipping
Shipping
Each tube contains lyophilized plasmid.
Storage
The lyophilized plasmid can be stored at ambient temperature for three months.
MYD88 Background Information
Myeloid differentiation primary response protein 88 (MyD88) is a critical adaptor protein involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) receptor family signaling controlling innate immune responses and inflammation. MyD88 links IL-1 receptor (IL-1R) or TLR family members to IL-1R-associated kinase (IRAK) family kinases via homotypic protein-protein interaction. Activation of IRAK family kinases leads to a variety of functional outputs, including the activation of nuclear factor-kappa B (NFκB), mitogen-activated protein kinases, and activator protein 1, making MyD88 a central node of inflammatory pathways. Genetic deletion of MyD88 function results in profound suppression of inflammation and reduced resistance of the host to pathogens indicating non-redundant roles of MyD88. Detection of MyD88 expression was to predict the prognosis of various human cancers, e.g., lymphoid, liver, and colorectal cancers.
Full Name
myeloid differentiation primary response 88
Research Areas
- Apoptosis Adaptor Proteins
- Adaptor Proteins
References
- Wang L, et al. (2018) Dual functional roles of the myd88 signaling in colorectal cancer development. Biomed Pharmacother 107 177-184.
- Gallot YS, et al. (2018) Myd88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice. Hum Mol Genet 27 (19): 3449-3463.
- Di Padova F, et al. (2018) Myd88 as a therapeutic target for inflammatory lung diseases. Expert Opin Ther Targets 22 (5): 401-408.
- Deguine J, et al. (2014) Myd88: A central player in innate immune signaling. F1000Prime Rep 6 97.
MYD88 cDNA ORF Clone, Human,Related Products
- MYD88 cDNA ORF Clone, Human, N-DYKDDDDK (Flag®) tagHG12936-NF
- MYD88 cDNA ORF Clone, Human, untaggedHG12936-UT
MYD88 cDNA ORF Clone, Mouse,Related Products
- MYD88 cDNA ORF Clone, Mouse, untaggedMG56953-UT
MYD88 cDNA ORF Clone, Rat,Related Products
- MYD88 cDNA ORF Clone, Rat, N-DYKDDDDK (Flag®) tagRG80819-NF
- MYD88 cDNA ORF Clone, Rat, C-His tagRG80819-CH
- MYD88 cDNA ORF Clone in Cloning Vector, RatRG80819-U
- MYD88 cDNA ORF Clone, Rat, C-Myc tagRG80819-CM
- MYD88 cDNA ORF Clone, Rat, C-OFPSpark® tagRG80819-ACR
- MYD88 cDNA ORF Clone, Rat, N-OFPSpark® tagRG80819-ANR
- MYD88 cDNA ORF Clone, Rat, C-DYKDDDDK (Flag®) tagRG80819-CF
- MYD88 cDNA ORF Clone, Rat, N-Myc tagRG80819-NM
- MYD88 Lentiviral cDNA ORF Clone, Rat, C-GFPSpark® tagRG80819-ACGLN
- MYD88 cDNA ORF Clone, Rat, C-HA tagRG80819-CY
- MYD88 cDNA ORF Clone, Rat, untaggedRG80819-UT
- MYD88 cDNA ORF Clone, Rat, N-GFPSpark® tagRG80819-ANG
- MYD88 cDNA ORF Clone, Rat, C-GFPSpark® tagRG80819-ACG
- MYD88 cDNA ORF Clone, Rat, N-His tagRG80819-NH
- Rat MYD88 qPCR Primer PairRP300783
- Compound LM9, a novel MyD88 inhibitor, efficiently mitigates inflammatory responses and fibrosis in obesity-induced cardiomyopathyAuthorZheng, X;Sun, C;Liu, Q;Lu, X;Fu, L;Liang, G;Zhang, X;Chen, G;Year2020JournalActa Pharmacol SinApplicationexpression&bindingFoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们